Navigation Links
Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study

ators on a submission to gain regulatory approval for Gleevec as adjuvant treatment for GIST."

Following the recommendation of a data monitoring committee, the study will be closed and patients in the study who are currently being treated with placebo may choose to receive one year of Gleevec.

In the study, patients were randomized to one of two treatment arms. Neither the patients nor physicians knew which treatment the patients were receiving. One patient group received Gleevec at a dose of 400 milligrams per day for one year, while the second group received placebo for one year. According to the study design, patients who developed a recurrence of their cancer while on a study therapy were unblinded to their treatment assignment. Those receiving placebo subsequently received Gleevec, while those already given Gleevec continued with this therapy but at a higher dose. Study results will be presented at a forthcoming scientific meeting.

Gastrointestinal stromal tumors (GIST) belong to a group of cancers known as soft tissue sarcomas that usually arise from the intestinal tract, with the most common site being the stomach followed by the small intestine. The incidence of GIST is estimated to be 4,500-6,000 new cases per year in the US (15-20 cases per million population), of which more than 90% are kit-positive.

Investigators in the NCI study reported that Gleevec therapy was well tolerated by most patients, with side effects similar to those observed in other clinical trials with Gleevec. These include nausea, diarrhea and swelling (edema). Information on more than 600 patients enrolled in the study was used in the analysis.

About Gleevec

Gleevec(R) (imatinib mesylate) is indicated for the treatment of patients with Kit (CD117)-positive unresectable and/or metastatic malignant gastrointestinal stromal tumors (GIST). The effectiveness of Gleevec in GIST is based on objective response rate. There are no controlled trials demon
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Protox Announces Positive Clinical Data from Prostate Cancer Study
5. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
Post Your Comments:
(Date:3/30/2015)... Calif., March 30, 2015 Shareholder rights attorneys ... proposed acquisition of Hyperion Therapeutics, Inc. (NASDAQ: HPTX ... On March 30, 2015, the two companies announced the ... Horizon will acquire Hyperion.  Under the terms of the ... each share of Hyperion common stock. ...
(Date:3/30/2015)... Calif. , March 30, 2015  EP ... development to shareholders, EPGL has opened negotiations with ... Option to License their new ophthalmic technologies. As ... Communications, Inc. have co-developed new contact lens technologies, ... It is estimated by some industry experts that ...
(Date:3/30/2015)... , March 30, 2015  A promising University of ... patients with a rare and lethal subtype of leukemia ... agreement with a new biotechnology company, Kura Oncology.  The ... work, led by Assistant Professor Jolanta Grembecka , ... at the University of Michigan, since 2009. ...
Breaking Medicine Technology:Robbins Arroyo LLP: Acquisition of Hyperion Therapeutics, Inc. (HPTX) by Horizon Pharma plc (HZNP) May Not Be in Shareholders' Best Interests 2Robbins Arroyo LLP: Acquisition of Hyperion Therapeutics, Inc. (HPTX) by Horizon Pharma plc (HZNP) May Not Be in Shareholders' Best Interests 3CooperVision, Inc. Seeks Intermediary as EP Global Communications, Inc., Opens Negotiations at $1.1B 2CooperVision, Inc. Seeks Intermediary as EP Global Communications, Inc., Opens Negotiations at $1.1B 3Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company 2Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company 3
(Date:3/30/2015)... March 31, 2015 A new ... patients and family members who may have been prescribed ... for morning sickness. The site was created in response ... GlaxoSmithKline in C.A. No. 11-10398-RWZ, filed with the United ... Star reports that this case alleged that GlaxoSmithKline ...
(Date:3/30/2015)... Falls Church, VA (PRWEB) March 31, 2015 ... two of the industry’s most respected inspection readiness ... workshop that walks attendees through the inspection process. ... FDA or national authority investigator and what they ... techniques include interactive role-playing exercises and roundtable discussions. ...
(Date:3/30/2015)... NY (PRWEB) March 31, 2015 ... Patricia Rede as a 2015 Professional Woman of ... distinction for leadership in nonprofits. As the largest, most-recognized ... virtually every industry and profession, the National Association of ... nearly 700,000 members and over 200 Local Chapters. , ...
(Date:3/30/2015)... 2015 The AAAHC, a private, ... the provision of high-quality health care through the ... and accreditation programs for 35 years. Through a ... to promote excellence in patient safety and care. ... and on-site evaluations by AAAHC expert surveyors, doctors, ...
(Date:3/30/2015)... Tenn. (PRWEB) March 30, 2015 Join ... third annual Hike2Heal 5k to raise funds to provide ... Academy in Uganda. Hike2Heal will take place on Saturday, ... at shelter No. 9 on 86 Vaughn Road in ... is located in an area without reliable medical care. ...
Breaking Medicine News(10 mins):Health News:Robert Gardner Law Announces Resource Site for Patients Prescribed Zofran During Pregnancy 2Health News:FDAnews Announces — GMP Inspections in Europe: Proven Strategies on How to Prepare Investigations, June 10-11, 2015, Frankfurt, Germany 2Health News:FDAnews Announces — GMP Inspections in Europe: Proven Strategies on How to Prepare Investigations, June 10-11, 2015, Frankfurt, Germany 3Health News:FDAnews Announces — GMP Inspections in Europe: Proven Strategies on How to Prepare Investigations, June 10-11, 2015, Frankfurt, Germany 4Health News:NAPW Announces Patricia Rede, President / Director / Founder of ECHOS of Children: Ending Chaos in Homes of Children, a 2015 Professional Woman of the Year 2Health News:Precinct Ambulatory Surgery Center Achieves Accreditation Association for Ambulatory Health Care Accreditation 2Health News:Hike2Heal and Rethink Church Raise Funds To Provide Healthcare for Ugandan Children with 3rd Annual Raise the Roof 5K on April 18 2
... at the University of Alabama at Birmingham's Magnetic Source ... , using MEG (magneto-encephalography) scanners to learn more about ... types of brain scans detail the geography of the ... the magnetic signals that neurons throw off as they ...
... and the name was shortened as Calgaria. But this has ... presentation// continue to insult those afflicted by mental sickness. ... about this, but those of us living with mental illness ... said Roy Muir, who suffers from depression and sits on ...
... ANN ARBOR, Mich.—By recognizing sugars, a technique developed ... sets the stage// for new cancer diagnosis and ... evidence points to assemblies of sugars called glycans ... accomplices in the growth and spread of tumors. ...
... stents do not prevent heart attacks as considered. Doctors ... to prevent heart attacks//. Stents are hollow tubes implanted ... ,This landmark study funded by the U.S. Department ... flow but are no more effective in preventing heart ...
... approximately 20% of children with Acute Lymphoblastic Leukemia (ALL) ... Of these, most will never be cured. ... to small numbers of cells which survived the treatment ... ,"However, it has been unclear whether these cells developed ...
... characteristics related to AAWL in adults between the ages ... lives//. ,Arthritis, a leading cause of ... work limitation (AAWL) can have substantial social and economic ... income. ,This study was published in ...
Cached Medicine News:Health News:MEG Scanners Are Mega Powerful 2Health News:A Sweet Step Toward New Cancer Therapies 2Health News:Stents Do Little to Prevent Heart Attacks 2Health News:AAWL Affects Quality of Life 2Health News:AAWL Affects Quality of Life 3
... of choice for customers performing routine and ... laboratories in more than 50 countries worldwide ... is pleased to announce the placement of ... customer centered development process of the BN ...
... to remove bone cement speedily and efficiently. , ... cement at the point of contact, allowing it ... feature of the apparatus is its ability to ... to the operator instantly. Probe position can thus ...
The Universal Knee Positioner(s)™ reduces surgeon fatigue while assisting in the stabilization of a patient's leg during surgury....
... blood salvage devices, the Haemonetics OrthoPAT system ... during and after surgery, but it is ... specifically to adapt to the perioperative, intermittent ... system consists of single-patient use disposable sets ...
Medicine Products: